Transaction · 0001943192-26-000004

Cline Christopher R.

Cline Christopher R., CFO, reported an open-market or private sale at Travere Therapeutics, Inc. involving 310.000000 shares for an estimated $13624.50. Reported holdings after the transaction were 118658.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
TVTXTravere Therapeutics, Inc.
Trade date
May 06, 2026
Filing date
May 07, 2026
View on SEC Insider profile
Disclosed value-$13.6kShares × reported price
Shares traded310$43.95 per share
Holdings after118kDirect
% of reported position traded0.26%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 118,968 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TVTX price since this filing

Daily closing prices, with the filing date and available return windows
TVTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -28.8%1w ago -28.8%1d ago +0.0%
Returns since7d +0.0%30d +2.1%90d +42.2%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001943192-26-000004
Common Stock
Transaction date
May 06, 2026
Filed May 07, 2026, 12:00 AM · 1d delay
Shares
310 sh
$43.95 per share
Estimated value
-$13.6k
Computed from shares × price
Holdings after
118,658 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF FINANCIAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    On January 31, 2024, the Reporting Person was granted performance restricted stock units (PSUs) covering 8,500 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance…

  2. F2

    Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This…

  3. F3

    This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to…

  4. F4

    Each PSU represents a contingent right to receive one share of the Issuer's common stock at target, subject to adjustment based on the achievement of applicable performance conditions.

Original filing · 0001943192-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TVTX